News &amp; Updates

Greater time-in-range (TIR), as assessed by continuous glucose monitoring (CGM), may lessen pain in patients with diabetic peripheral neuropathy (DPN), a new study has found.

Better time in range eases painful diabetic neuropathy

Vitamin D protects against diabetes among people with healthy sleep patterns

Individuals with higher circulating vitamin D concentrations are better protected against type 2 diabetes, especially those with healthier sleep patterns, a study has found.

Vitamin D protects against diabetes among people with healthy sleep patterns

$Delayed denosumab treatment may up vertebral fracture risk$

Delayed denosumab treatment may up vertebral fracture risk

17 Sep 2020 by

In patients with osteoporosis treated with denosumab, a long interval between injections could raise their risk of vertebral fracture, a UK-based retrospective study showed.

Delayed denosumab treatment may up vertebral fracture risk

Anthropometric factors insufficient to detect prediabetes in kids

Anthropometric measures are not sufficiently accurate for predicting elevated fasting plasma glucose and glycated haemoglobin in children, a new study reports.

Anthropometric factors insufficient to detect prediabetes in kids

Hormone combination helps short teens become taller

In teens with short stature, the combination of gonadotropin releasing hormone analogue (GnRHa) and recombinant human growth hormone (rhGH) yields a significant increase in adult height, as shown in a study.

Hormone combination helps short teens become taller

Cardiovascular risk factors tied to hearing impairment in men

16 Sep 2020

Men with cardiovascular risk factors, hypertension in particular, appear to be at a higher risk of hearing impairment (HI), reports a recent Japan study.

Cardiovascular risk factors tied to hearing impairment in men

16 Sep 2020

5α-reductase inhibitors do not up risk of depression

Treatment with a 5α-reductase inhibitor does not appear to contribute to an elevated risk of depression, a study has found.

5α-reductase inhibitors do not up risk of depression

DPP-4 inhibitors may up risk of bullous pemphigoid

Use of dipeptidyl-peptidase 4 (DPP-4) inhibitors is linked to the development of bullous pemphigoid, although the risk increase appears to be limited to linagliptin, according to the results of a meta-analysis.

DPP-4 inhibitors may up risk of bullous pemphigoid